James R. Springstead

James R. Springstead

Auto-generated profile, based on publicly available information

James R. Springstead

Western Michigan University, Kalamazoo, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2012 in Circulation Research
Verified
Journal Article
Closed access
PDF file
SLSangderk Lee
Sangderk Lee
KBKonstantin G. Birukov
Konstantin G. Birukov
CRCasey E. Romanoski
Casey E. Romanoski
JSJames R. Springstead
James R. Springstead
ALAldons J. Lusis
Aldons J. Lusis
JBJudith A. Berliner
Judith A. Berliner
There is increasing clinical evidence that phospholipid oxidation products (Ox-PL) play a role in atherosclerosis. This review focuses on the mechanisms by which Ox-PL interact with endothelial cells, monocyte/macrophages, platelets, smooth muscle cells, and HDL to promote atherogenesis. In the past few years major progress has been made in identifying these mechanisms. It has been recognized that Ox-PL promote phenotypic changes in these cell types that have long-term consequences for the vessel wall. Individual Ox-PL responsible for specific cellular effects have been identified. A model of the configuration of bioactive truncated Ox-PL within membranes has been developed that demonstrates that the oxidized fatty acid moiety protrudes into the aqueous phase, rendering it accessible for receptor recognition. Receptors and signaling pathways for individual Ox-PL species are now determined and receptor independent signaling pathways identified. The effects of Ox-PL are mediated both by gene regulation and transcription independent processes. It has now become apparent that Ox-PL affects multiple genes and pathways, some of which are proatherogenic and some are protective. However, at concentrations that are likely present in the vessel wall in atherosclerotic lesions, the effects promote atherogenesis. There have also been new insights on enzymes that metabolize Ox-PL and the significance of these enzymes for atherosclerosis. With the knowledge we now have of the regulation and effects of Ox-PL in different vascular cell types, it should be possible to design experiments to test the role of specific Ox-PL on the development of atherosclerosis.

1 April 2013 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
ACArnab Chattopadhyay
Arnab Chattopadhyay
MNMohamad Navab
Mohamad Navab
GHGreg Hough
Greg Hough
FGFeng Gao
Feng Gao
DMDavid Meriwether
David Meriwether
AFAlan M. Fogelman
Alan M. Fogelman
Arnab Chattopadhyay, Mohamad Navab, Greg Hough, Feng Gao, David Meriwether, Victor Grijalva, James R. Springstead, Mayakonda N. Palgnachari, Ryan Namiri-Kalantari, Feng Su, Brian J. Van Lenten, Alan C. Wagner, G. M. Anantharamaiah, Robin Farias-Eisner, Srinivasa T. Reddy, Alan M. Fogelman

22 December 2007 in Extremophiles
Verified
Journal Article
Closed access
PDF file
DLDenton Lai
Denton Lai
JSJames R. Springstead
James R. Springstead
HMHarold G. Monbouquette
Harold G. Monbouquette

1 July 2012 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
JSJames R. Springstead
James R. Springstead
BGB. Gabriel Gugiu
B. Gabriel Gugiu
SLSangderk Lee
Sangderk Lee
SCSeung Cha
Seung Cha
AWAndrew D. Watson
Andrew D. Watson
JBJudith A. Berliner
Judith A. Berliner
Oxidation products of 1-palmitoyl-2-arachidonoyl-sn-glycerol-3-phosphatidylcholine (PAPC), referred to as OxPAPC, and an active component, 1-palmitoyl-2-(5,6-epoxyisoprostane E2)-sn-glycero-3-phosphatidylcholine (PEIPC), accumulate in atherosclerotic lesions and regulate over 1,000 genes in human aortic endothelial cells (HAEC). We previously demonstrated that OxPNB, a biotinylated analog of OxPAPC, covalently binds to a number of proteins in HAEC. The goal of these studies was to gain insight into the binding mechanism and determine whether binding regulates activity. In whole cells, N-acetylcysteine inhibited gene regulation by OxPAPC, and blocking cell cysteines with N-ethylmaleimide strongly inhibited the binding of OxPNB to HAEC proteins. Using MS, we demonstrate that most of the binding of OxPAPC to cysteine is mediated by PEIPC. We also show that OxPNB and PEIPE-NB, the analog of PEIPC, bound to a model protein, H-Ras, at cysteines previously shown to regulate activity in response to 15-deoxy-Δ12,14-prostaglandin J2 (15dPGJ2). This binding was observed with recombinant protein and in cells overexpressing H-Ras. OxPAPC and PEIPC compete with OxPNB for binding to H-Ras. 15dPGJ2 and OxPAPC increased H-Ras activity at comparable concentrations. Using microarray analysis, we demonstrate a considerable overlap of gene regulation by OxPAPC, PEIPC, and 15dPGJ2 in HAEC, suggesting that some effects attributed to 15dPGJ2 may also be regulated by PEIPC because both molecules accumulate in inflammatory sites. Overall, we provide evidence for the importance of OxPAPC-cysteine interactions in regulating HAEC function.

7 July 2025 in ACS Applied Nano Materials
Verified
Journal Article
Open access
ZLZhengbai Li
Zhengbai Li
ANAleesha Nabhai
Aleesha Nabhai
OWOliver Charles Wasson
Oliver Charles Wasson
IMIlma Sang Mainardi
Ilma Sang Mainardi
JWJason Wang
Jason Wang
JLJinghao Li
Jinghao Li
Hydrogels and aerogels, both derived from three-dimensional gel networks, have gained prominence across various applications including biomedical, environmental, and energy fields due to their unique physicochemical properties. Hydrogels are water-swollen polymer networks prized for biocompatibility and stimuli responsiveness, while aerogels, characterized by ultralow density and high porosity, offer superior performance in thermal insulation, catalysis, and sensing. The transformation from hydrogel to aerogel, primarily governed by the drying process, is critical to preserving structural integrity and achieving desired functionalities. This review explores sol–gel synthesis strategies and compares major drying techniques, highlighting their advantages, limitations, and influence on final aerogel properties. We further review recent advances in hydrogel materials, including inorganic, organic, and hybrid systems, and how their tailored structures contribute to aerogel performance. Future innovations are anticipated through molecular-level design, cellular structure computation, and AI-driven manufacturing optimization. Addressing challenges in cost, scalability, and long-term stability will be pivotal in transitioning aerogels from niche materials to transformative solutions in fields such as energy storage, environmental remediation, biomedicine, aerospace, and others.

1 May 2012 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PDF file
SLSangderk Lee
Sangderk Lee
JSJames R. Springstead
James R. Springstead
BPBrian W. Parks
Brian W. Parks
CRCasey E. Romanoski
Casey E. Romanoski
RPRoland Palvolgyi
Roland Palvolgyi
DVDevendra K. Vora
Devendra K. Vora
Objective—: Atherosclerosis is a chronic inflammatory disease initiated by monocyte recruitment and retention in the vessel wall. An important mediator of monocyte endothelial interaction is the chemokine interleukin (IL)-8. The oxidation products of phospholipids, including oxidized 1-palmitoyl-2-arachidonyl- sn -glycerol-3-phosphocholine (Ox-PAPC), accumulate in atherosclerotic lesions and strongly induce IL-8 in human aortic endothelial cells (HAECs). The goal of this study was to identify the proximal events leading to induction of IL-8 by Ox-PAPC in vascular endothelial cells. Methods and Results—: In a systems genetics analysis of HAECs isolated from 96 different human donors, we showed that heparin-binding EGF-like growth factor (HBEGF) transcript levels are strongly correlated to IL-8 induction by Ox-PAPC. The silencing and overexpression of HBEGF in HAECs confirmed the role of HBEGF in regulating IL-8 expression. HBEGF has been shown to be stored in an inactive form and activation is dependent on processing by a dysintegrin and metalloproteinases (ADAM) to a form that can activate the epidermal growth factor (EGF) receptor. Ox-PAPC was shown to rapidly induce HBEGF processing and EGF receptor activation in HAECs. Using siRNA we identified 3 ADAMs that regulate IL-8 induction and directly demonstrated that Ox-PAPC increases ADAM activity in the cells using a substrate cleavage assay. We provide evidence for one mechanism of Ox-PAPC activation of ADAM involving covalent binding of Ox-PAPC to cysteine on ADAM. Free thiol cysteine analogs showed inhibition of IL-8 induction by Ox-PAPC, and both a cysteine analog and a cell surface thiol blocker strongly inhibited ADAM activity induction by Ox-PAPC. Using microarray analyses, we determined that this ADAM pathway may regulate at least 30% of genes induced by Ox-PAPC in HAECs. Conclusion—: This study is the first report demonstrating a role for the ADAM-HBEGF-EGF receptor axis in Ox-PAPC induction of IL-8 in HAECs. These studies highlight a role for specific ADAMs as initiators of Ox-PAPC action and provide evidence for a role of covalent interaction of Ox-PAPC in activation of ADAMs.